Endocrine-enriched stem cell-derived islets improve long-term safety in vivo
Eunike Sawitning Ayu Setyono, Nicole Katarina Rogers, Katharina Scheibner, Silvia Schirge, Hélène Reich, Michael Sterr, Timucin Öztürk, Sören Franzenburg, Väinö Lithovius, Heiko Lickert
This study improves the safety of stem cell-derived islets by enriching endocrine cells and reducing off-target cell types, enhancing long-term in vivo outcomes.
bioRxiv · Aug 22, 2025 · PreprintBioengineering